Use of Neutron Therapy in the Management of Locally Advanced Nonresectable Primary or Recurrent Rectal Cancer
Inoperable locally advanced or inoperable recurrent rectal cancer is a difficult problem. Tenesmus, discharge, bleeding and pelvic pain are frequently present and often are associated with infiltration of the sacral plexus. The value of radiotherapy in managing such patients is being appreciated, although up to 40% of the treated patients have no symptomatic response. Improvement in tumor response and control has been scored through efforts to overcome the radioresistance of the hypoxic tumor cells by neutron irradiation. This article is an account of the activity of neutron radiotherapy in such patients. Over 350 patients were entered in studies comparing neutrons used alone and neutrons used in a mixed-beam treatment schedule. At present no therapeutic gain for long-lasting survival has been achieved; however, local control and pain improvement seems to be better with neutrons than with photons.
KeywordsRectal Cancer Fast Neutron Tumor Control Rate Neutron Dose Recurrent Rectal Cancer
Unable to display preview. Download preview PDF.
- Breteau N, Destembert B, Favre A, Sabattier R, Schlienger M (1986) An interim assessment of the experience of fast neutron boost in inoperable rectal carcinoma in Orléans. Bull Cancer/Radiother 73: 591–595Google Scholar
- Engenhart R, Kimmig B, Wannenmacher M, Höver KH, Hesse BM, Lorenz JW (1989) Experience with the computer controlled weighted moving beam therapy (WMBT) in routine clinical use. In: Blattmann H (ed) Proceedings of the International Heavy Particle Therapy Workshop ( PTCOG/EORTC/ECNEU ), Villingen 1989, pp 38–42Google Scholar
- Engenhart R, Kimmig B, Strauß G, Höver KH, Rohman J, Haberkorn U, van Kaick G, Wannenmacher M (1992) Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 4: 203–212Google Scholar
- Field SB, Fowler JF (1984) The biological basis for neutron therapy. J Eur Radiother 3: 170–175Google Scholar
- Moertel CG, Gunderson LL, Mailliard JA, McKenna PJ, Martenso JA, Burch, PA, Cha SS (1994) Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol 1: 21–27Google Scholar
- Rominger CJ, Helber RD, Gunderson LL et al (1985) Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery: Radiation Therapy Oncology Group study (76–16). Am J Clin Oncol 8: 118–127PubMedCrossRefGoogle Scholar